CD4+ T cell responses against SARS-CoV-2 were more prominent than the CD8+ T cell response in adults with mild-to-moderate infection (8, 15, 16), while qualitatively impaired CD4+ T cell responses have been reported for critically ill patients (15). The gene discussed is CD8A; the disease is infection.